QR Kod

Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-III

Abstract Background The process of obtaining prior informed consent for experimental treatment does not fit well into the clinical reality of acute and intensive care. The therapeutic window of interventions is often short, which may reduce the validity of the consent and the rate of enrolled partic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Maria Linander Vestager, Mathias Lühr Hansen, Gorm Greisen, the SafeBoosC-III trial group
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMC 2024-04-01
Seri Bilgileri:Trials
Konular:
Online Erişim:https://doi.org/10.1186/s13063-024-08074-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!